Viewing Study NCT06422858


Ignite Creation Date: 2025-12-25 @ 12:01 AM
Ignite Modification Date: 2026-01-04 @ 6:24 PM
Study NCT ID: NCT06422858
Status: RECRUITING
Last Update Posted: 2025-05-09
First Post: 2024-05-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Sequential Tegafur-gimeracil-oteracil Potassium Capsule (s-1) and Serplulimab Following Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma
Sponsor: Zhejiang Cancer Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module